Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
As 2017 draws to a close, I’ve been reflecting on another year in cancer research. As Chief Executive Officer...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
When we think about “cancer scientists,” we typically conjure images of physicians treating their patients or biologists analyzing cells...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...
The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the antibody–drug conjugate brentuximab vedotin (Adcetris)...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...